IDEAYA Biosciences (IDYA) Shares Outstanding (Diluted Average) (2021 - 2025)

IDEAYA Biosciences has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $88.5 million for Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $88.5 million, up 8.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $88.5 million (up 8.33% YoY), and the FY2025 annual result was $88.5 million, up 8.33% from the prior year.
• Shares Outstanding (Diluted Average) came in at $88.5 million for Q4 2025 at IDEAYA Biosciences, roughly flat from $88.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $88.5 million in Q4 2025 to a low of $35.3 million in Q4 2021.
• The 5-year median for Shares Outstanding (Diluted Average) is $67.6 million (2023), against an average of $65.3 million.
• Across the five-year window, Shares Outstanding (Diluted Average) jumped 55.28% in 2024 and rose 8.33% in 2025, its largest moves.
• IDEAYA Biosciences' Shares Outstanding (Diluted Average) stood at $35.3 million in 2021, then increased by 17.57% to $41.4 million in 2022, then surged by 38.79% to $57.5 million in 2023, then jumped by 42.0% to $81.7 million in 2024, then advanced by 8.33% to $88.5 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $88.5 million (Q4 2025), $88.5 million (Q2 2025), and $88.4 million (Q1 2025), per Business Quant data.